Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.332
+0.092 (2.17%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $160.39 million as of April 10, 2026. Its market cap has increased by 9.63% in one year.
Market Cap
160.39M
Enterprise Value
46.98M
1-Year Change
9.63%
Ranking
Category
Stock Price
$4.33
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $160.39M, a decrease of -73.07%. That is a compound annual growth rate of -14.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 160.39M | 0.16% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 163.44M |
| Cartesian Therapeutics | 163.03M |
| Unicycive Therapeutics | 162.78M |
| Tiziana Life Sciences | 162.08M |
| Agenus | 161.27M |
| Whitehawk Therapeutics | 160.94M |
| Spero Therapeutics | 157.46M |
| Tenaya Therapeutics | 157.37M |